MoonLake Immunotherapeutics (NasdaqCM:MLTX) 2025 R&D Day Transcript
MoonLake Immunotherapeutics (NasdaqCM:MLTX) 2025 R&D Day September 29, 2025 08:00 AM ET Company ParticipantsMatthias Bodenstedt - CFOJorge Santos da Silva - Founder, CEO & DirectorKristian Reich - Founder & Chief Scientific OfficerAlexandra Kimball - Professor - DermatologyMatthias BodenstedtWelcome, everyone. Good morning, good afternoon. Thank you for joining today's webcast. My name is Matthias Bornstedt. I'm the Chief Financial Officer of MoonLake Immunotherapeutics. As usual, I'm joined here by our Co- ...